Members Trust Co Buys 51 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Members Trust Co lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,085 shares of the healthcare conglomerate’s stock after acquiring an additional 51 shares during the period. Members Trust Co’s holdings in UnitedHealth Group were worth $570,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the stock. Moneta Group Investment Advisors LLC increased its holdings in UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after purchasing an additional 11,812,017 shares during the period. Norges Bank purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $5,210,004,000. Arrowstreet Capital Limited Partnership increased its holdings in shares of UnitedHealth Group by 1,682.4% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after acquiring an additional 2,540,538 shares during the last quarter. International Assets Investment Management LLC increased its holdings in shares of UnitedHealth Group by 53,573.1% in the 4th quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock valued at $1,238,515,000 after acquiring an additional 2,348,107 shares during the last quarter. Finally, Barclays PLC boosted its position in shares of UnitedHealth Group by 143.4% in the 2nd quarter. Barclays PLC now owns 3,494,100 shares of the healthcare conglomerate’s stock valued at $1,679,401,000 after purchasing an additional 2,058,829 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

UNH stock traded up $6.43 during midday trading on Monday, reaching $445.63. The company had a trading volume of 5,352,440 shares, compared to its average volume of 4,304,973. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. The stock has a 50 day moving average price of $492.29 and a 200 day moving average price of $516.34. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The firm has a market capitalization of $410.84 billion, a PE ratio of 18.74, a P/E/G ratio of 1.20 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. During the same period in the previous year, the firm posted $5.34 earnings per share. UnitedHealth Group’s quarterly revenue was up 14.1% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Incorporated will post 27.7 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.69%. UnitedHealth Group’s dividend payout ratio is presently 31.54%.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

Analysts Set New Price Targets

UNH has been the subject of a number of research analyst reports. Oppenheimer reissued an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 10th. Royal Bank of Canada restated an “outperform” rating and set a $596.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 29th. Piper Sandler reduced their price objective on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 17th. Finally, Barclays started coverage on UnitedHealth Group in a research note on Wednesday, March 6th. They set an “overweight” rating and a $551.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $573.80.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.